Takeshi Arashiro
Overview
Explore the profile of Takeshi Arashiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
430
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arashiro T, Berba R, Calayo J, Kris M, Garcia R, Suzuki S, et al.
Western Pac Surveill Response J
. 2025 Mar;
16(1):1-12.
PMID: 40034498
Objective: We examined sociobehavioural factors associated with SARS-CoV-2 infection and estimated COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection in the Philippines. Such studies are limited in low- and middle-income countries,...
2.
Arashiro T, Solante R, Sayo A, Garcia R, Kris M, Suzuki S, et al.
Epidemiol Infect
. 2024 Dec;
153():e18.
PMID: 39703003
COVID-19 vaccine effectiveness (VE) studies are limited in low- and middle-income countries. A case-control study was conducted among COVID-19 and other pneumonia patients admitted to a hospital in the Philippines...
3.
Arashiro T, Kramer R, Jin J, Kano M, Wang F, Miyairi I
Influenza Other Respir Viruses
. 2024 Nov;
18(11):e70045.
PMID: 39572401
Background: Respiratory syncytial virus (RSV) and influenza virus are major viral etiologies of pediatric lower respiratory tract infection, but comparative data on inpatient burden are lacking. Methods: Using a large-scale...
4.
Arashiro T, Tajima Y, Ban Y, Loiacono M, Ideguchi M, de Courville C
Influenza Other Respir Viruses
. 2024 Nov;
18(11):e70032.
PMID: 39533850
Background: Seasonal influenza may lead to severe complications, including respiratory and cardiovascular disease, that result in considerable healthcare resource utilization (HCRU) and mortality, particularly in older individuals. This real-world study...
5.
Otsuka M, Kasamatsu A, Arima Y, Takahashi T, Arashiro T, Komase K, et al.
Jpn J Infect Dis
. 2024 Sep;
78(1):51-54.
PMID: 39343557
In Japan, as elsewhere, the coronavirus disease 2019 (COVID-19) pandemic has affected notification trends of respiratory syncytial virus (RSV) infection. Here, we describe the epidemiological trends of cases of RSV...
6.
Nagasawa K, Ohata M, Igarashi A, Arashiro T, Ogawa T, Ohkusu M, et al.
Int J Infect Dis
. 2024 Sep;
149:107252.
PMID: 39343126
Objectives: In Japan, population-based epidemiological data on respiratory syncytial virus (RSV) infections are limited. To elucidate the epidemiology of RSV before the introduction of new prophylactic drugs, we conducted a...
7.
Arima Y, Takahashi T, Kasamatsu A, Arashiro T, Kobayashi Y, Otsuka M, et al.
J Epidemiol
. 2024 Aug;
35(2):106-107.
PMID: 39098036
No abstract available.
8.
Arashiro T, Arima Y, Takahashi T, Taniguchi K, Horiguchi H, Suzuki M
Jpn J Infect Dis
. 2024 Mar;
77(5):296-300.
PMID: 38556302
In Japan, based on the National Epidemiological Surveillance of Infectious Diseases (NESID) Program, influenza cases from approximately 5,000 sentinel sites are monitored weekly as part of influenza surveillance (as the...
9.
Arima Y, Tsuchihashi Y, Takahara O, Shimbashi R, Arashiro T, Kasamatsu A, et al.
Western Pac Surveill Response J
. 2024 Mar;
15(1):1-2.
PMID: 38500773
No abstract available.
10.
Miyamoto S, Nishiyama T, Ueno A, Park H, Kanno T, Nakamura N, et al.
Proc Natl Acad Sci U S A
. 2023 Dec;
120(52):e2314808120.
PMID: 38134196
Infectious virus shedding from individuals infected with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is used to estimate human-to-human transmission risk. Control of SARS-CoV-2 transmission requires identifying the immune correlates that...